Temporal relationship of muscle weakness and pain reduction in subjects treated with botulinum toxin A

J Pain. 2003 Apr;4(3):159-65. doi: 10.1054/jpai.2003.435.

Abstract

Botulinum toxin A has demonstrated efficacy in relieving pain in spastic and nonspastic muscle conditions. This analgesic property has generally been attributed to muscular relaxation. This study demonstrates initial muscular relaxation and concomitant pain relief in a masticatory muscle model. However, as muscle power returns to normal, pain relief is still very evident. This result suggests that the analgesic effect attributed to botulinum toxin is more complex than simple muscular relaxation.

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Adult
  • Bite Force
  • Botulinum Toxins, Type A / therapeutic use*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Muscle Relaxation / drug effects*
  • Muscle Weakness / drug therapy*
  • Muscle Weakness / etiology
  • Neuromuscular Agents / therapeutic use*
  • Pain / drug therapy*
  • Pain / etiology
  • Pain Measurement
  • Prospective Studies
  • Temporomandibular Joint Disorders / complications*
  • Time Factors

Substances

  • Neuromuscular Agents
  • Botulinum Toxins, Type A